AbuDhabi Dubai STOB Series 22 Investment Enters into Favorable Tender Offer Agreement with MINDOL HOLDINGS
AbuDhabi Dubai STOB Series 22 Investment Limited Partnership, hereafter AbuDhabi22, and MINDOL HOLDINGS LIMITED, hereafter MINDOL, listed on the Hong Kong-based Coinsuper exchange (https://www.coinsuper.com) have reached an agreement where AbuDhabi22 will acquire the minimum 33.3 percent holding for the MINDOL cryptocurrency (MIN, https://mindol.net) to be issued by MINDOL, via a tender offer (TOB).
Implementation of the TOB will serve to strengthen the strategic partnership with MINDOL. Both companies expect that the AbuDhabi22 bid will greatly exceed any bids made via ordinary exchange channels. With a bid offering at a stable price, the TOB method was chosen for its strategic worth.
The MINDOL business vision for 2019 sets a target for its cryptocurrency, from among the more than 2,000 types of cryptocurrencies currently available, to have a top-30 market capitalization. As a business that focuses on "the fusion of subculture and blockchain," they will develop an online game that takes advantage of blockchain technology, after creating a development budget of 150 million USD. An exclusive MINDOL wallet, for use on smartphones, will also be developed, to be used for the existing Influencer Voting project and the upcoming, to-be-developed, online game. There will also be announcements for new MINDOL media strategies and projects nearer to the end of September 2018.
Tender Offer Price and Period
Tender Offer Price: Ranging from 0.97
USD at TOB STAGE 1 to 10.2 USD at TOB STAGE 5
Reference Value 1:
Token sale final price 0.45 USD
Reference Value 2: Listing start
price 0.54 USD
Starting Day of Tender Offer: September 16, 2018
Exercise
Period：10 days after the completion of the tender offer
Offer
Conditions: Limited to token holders of at least 3,000 MIN, or MINDOL,
as listed on the Coinsuper exchange.
See the following website for
more information on bid conditions and objectives:
http://mindol.net
The original source-language text of this announcement is the official, authoritative version. Translations are provided as an accommodation only, and should be cross-referenced with the source-language text, which is the only version of the text intended to have legal effect.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180920005232/en/
Contact information
AbuDhabi Dubai STOB Series 22 Investment Limited Partnership
Mohiuddin
Mohamed
mindoltob@ad22stob.org
or
MINDOL
HOLDINGS LIMITED
Fumihiro Fukuhara
info@mindol.net
Twitter:
https://twitter.com/mindolproject
Telegram:
https://t.me/MINDOLGLOBAL,
for global inquiries
Telegram: https://t.me/MINDOLGROUP,
for inquiries in Japanese
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers24.4.2024 16:00:00 EEST | Press release
Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts. As detailed in its complaint, Exergen’s lawsuit is a response to an effort by Baxter to censor true statements that Exergen has made in a scientific journal about a matter of public concern, among other issues. Through its lawsuit, Exergen seeks a legal declaration that its statements are not only true, but that they constitute First Amendment protected speech. Exergen looks forward to having this matter resolved in a court of law. Click here to read the formal complaint. About Exergen Corporation Exergen invented, manufactures, and markets two series of the TemporalScanner thermometer: a professional version for hospitals and clinics, and a consumer version sold in major retailers nationwide. More than three billion temperatures are taken each year with TemporalScanners. Used in thousands of hospitals and clinics across the country as w
‘World of Coffee & World Barista Championship Busan 2024’ to Launch on May 1st24.4.2024 16:00:00 EEST | Press release
Global coffee figures and baristas will gather at BEXCO, Busan in May. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424527060/en/ World of Coffee & World Barista Championship Busan is held from May 1st to 4th at BEXCO, Busan. (Graphic: EXPORUM) Specialty coffee industry professionals from around the world will gather at BEXCO, Busan, from May 1-4, 2024, for the inaugural World of Coffee in Asia. This event will also feature the 2024 World Barista Championship, bringing together top baristas from across the globe. The Specialty Coffee Association (SCA) is working with host Busan Metropolitan City and organizer EXPORUM, with support of the 2024 Portrait Country, Indonesia, to debut World of Coffee in Busan, marking a significant milestone for the Asian coffee community. Over 20,000 global attendees, including 12,000 industry professionals from 70+ countries, are expected to visit BEXCO, anticipating contributions not only
Open Source Database Leader Percona Appoints Liz Warner to Chief Technology Officer24.4.2024 16:00:00 EEST | Press release
Percona, a leader in enterprise-grade, open source database software, support, and services, today announced the appointment of Liz Warner as its new Chief Technology Officer, to help meet the growing demand to make data simpler, faster, and easier to manage. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424498483/en/ Liz Warner, Chief Technology Officer, Percona (Photo: Business Wire) An industry veteran, Warner comes to Percona with decades of technical and senior leadership experience; including a proven track record of driving successful organizational transformations. As CTO, she will play an instrumental role in the development and implementation of Percona’s ever-expanding collection of database solutions, including the much-anticipated Percona Everest, an open source cloud-native database platform. “We’ve reached a pivotal moment in open source, and Percona is doubling down on its commitment to staying open throu
The Antera Brand Back at the Summit of Light Alloy-wheel Producers24.4.2024 15:23:00 EEST | Press release
The Antera brand makes its comeback on the world stage during the 2024 Milan Design Week with a new collection of light alloy wheels. A premium made-in-Italy brand, Antera combines timeless design, cutting-edge technology, and the determination to overcome any obstacle. Its ambassador is the football champion Roberto Baggio, who, thanks to his successful career and winning mindset, is the perfect embodiment of the Italian’s brand spirit of 'No Compromise'. The new Antera advertising campaign’s slogan, "Where instinct meets genius, the myth becomes legend", attests to the dedication, courage, and vision of a brand which is able to project itself into the future. Antera was founded in Milan in 1991 and has produced some of the most iconic models in the field, including the Type 109, a three-spoke wheel that was named as “Alloy Wheel Design of the Year 1994”. G.M.P. Group, a company specialized in the global design and production of alloy wheels, is responsible for bringing it back to its
Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech24.4.2024 15:15:00 EEST | Press release
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation providers to readily support the adoption of Parse’s Evercode™ single cell products. By combining powerful automation with the Parse Evercode platform, customers will have unprecedented access to high-throughput single cell sequencing, enabling them to rapidly generate insights for large-scale studies. Parse’s Evercode single cell technology has enabled researchers to scale their projects to millions of cells or nuclei and has been widely adopted across oncology, immunology, neuroscience, basic research, and drug and target discovery. To facilitate scaling up these projects and to help researchers generate insights more quickly, Parse has developed automation-friendly workflows for high-throughput sample fixation, single cell barcoding, and library preparation. As key providers in the new Labor
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom